Use of ppar alpha agonists for the treatment of vascular and renal diseases
CA 2481371 A1 · Owner: Taylor, Carla · Inventors: Taylor, Carla; Zahradka, Peter
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Activation of peroxisome proliferator activated receptor alpha (PPAR.alpha.) by administration of therapeutic amounts of a PPAR.alpha. agonist WY-14643, inhibits the proliferation of vascular smooth muscle cells hepatoma cells and , human renal proximal tubule cells. WY-14643 may be applicable as a medicament for the treatment of proliferative vascular disease (atherosclerosis hypertension), revascularization-induced injury (restenosis) and chronic renal failure.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 11, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 11, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 11, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.